about
Structure, genetic localization, and identification of the cardiac and skeletal muscle transcripts of the human integrin alpha7 gene (ITGA7)Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic miceAsymmetric septal hypertrophy in heterozygous cMyBP-C null miceSynthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.Distinctive serum miRNA profile in mouse models of striated muscular pathologies.Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve AbnormalitiesCardiac Myosin-binding protein C modulates the tuning of the molecular motor in the heartERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C geneStriated muscle laminopathies.Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome.AT1 blockade abolishes left ventricular hypertrophy in heterozygous cMyBP-C null mice: role of FHL1.Genetics of laminin α2 chain (or merosin) deficient congenital muscular dystrophy: from identification of mutations to prenatal diagnosisSpontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin α2 chain geneIdentification of homozygous and heterozygous dy 2J mice by PCRRescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A/C gene mutationPartial laminin alpha2 chain deficiency in a patient with myopathy resembling inclusion body myositisCongenital muscular dystrophy with primary partial laminin alpha2 chain deficiency: molecular studyEffect of genetic background on the cardiac phenotype in a mouse model of Emery-Dreifuss muscular dystrophyAlteration of performance in a mouse model of Emery-Dreifuss muscular dystrophy caused by A-type lamins gene mutation
P50
Q28139465-1D215717-2F5D-4D5F-B0C7-999575333492Q28251438-964F6A1D-B669-4B72-8A77-2C9B9EC2FDD0Q28271615-711CDFA0-76EC-4C5C-80E5-9ABCDE70EAB0Q34458035-77F9D770-B6AA-439C-8ADD-3CE595270C11Q34589538-9C6404E1-0439-40DC-8F6F-F00AC3BC54D5Q36498609-BCA3BC3F-0E13-482E-820B-755FDD2E0B5DQ36737220-25D2000D-A0D9-476F-98A6-97C48E0B4F99Q37367994-9448B360-EE45-4882-A48A-682A6FBA99C8Q38179769-4DEBF04B-0510-4944-844C-494A3F13AAE0Q47987064-81606A3A-7585-4165-83FB-F7B2DE642031Q51060626-D89C9759-15D7-4039-92A8-07A08F8FDA87Q57640124-F71EDAB0-998A-4CC5-B432-03C9FC46A6C7Q58108941-A07FFCD2-B0B6-4C23-A32C-37DFCC5BA99FQ58109219-86AEB709-3676-42FF-9135-E5946D3F9406Q63531097-E294CC9C-7E51-4D00-BEE7-636C68BC0F89Q73892963-9ED27744-AEBB-4B48-A213-303DC2F9F81CQ74601951-679CC9E0-DFE6-4CF5-8BEA-E245A0D76556Q92159085-48DDF48A-7BAE-4281-89BB-04950107A997Q92904388-4878A576-E859-40D3-AD18-3F7DAC60C643
P50
description
researcher ORCID ID = 0000-0003-2663-4864
@en
wetenschapper
@nl
name
N Vignier
@ast
N Vignier
@en
N Vignier
@nl
type
label
N Vignier
@ast
N Vignier
@en
N Vignier
@nl
prefLabel
N Vignier
@ast
N Vignier
@en
N Vignier
@nl
P106
P31
P496
0000-0003-2663-4864